Retinopathy of prematurity in infants with birth weight ≥ 1250 grams-incidence, severity, and screening guideline cost-analysis

Journal of AAPOS

Volumn 11, Issue 2, 2007, Pages 208-210

  Yang, Michael B ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIRTH WEIGHT; COST BENEFIT ANALYSIS; DISEASE SEVERITY; HUMAN; INCIDENCE; INFANT; LETTER; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; RISK FACTOR; SCREENING; VISUAL ACUITY; VISUAL IMPAIRMENT;

BIRTH WEIGHT; COST OF ILLNESS; COST-BENEFIT ANALYSIS; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; PRACTICE GUIDELINES; RETINOPATHY OF PREMATURITY; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 34047159255     PISSN: 10918531     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaapos.2006.07.006     Document Type: Letter

References (2)

1. Yanovitch T.L., Siatkowski R.M., Mcaffree M.A., and Corff K.E. Retinopathy of prematurity in infants with birth weight ≥ 1250 grams-incidence, severity, and screening guideline cost-analysis. J AAPOS 10 (2006) 128-134
2. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol 119 (2001) 1110-1118